Glucose Metabolism Disorders  >>  AMG 108  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 108 / AstraZeneca
NCT00661921: A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

Withdrawn
2
0
NA
AMG 108, Placebo
Amgen
Diabetes Mellitus
06/09
10/09

Download Options